Evidence map›Paper›PMID 37360424›Full record

ArticleACS omega2023

Pd-Coordinated Salinidol-Modified Mixed MOF: An Excellent Active Center for Efficient Nitroarenes Reduction and Selective Oxidation of Alcohols.

Hassan Keypour, Jamal Kouhdareh, Sedigheh Alavinia, Rahman Karimi-Nami, İdris Karakaya

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hassan KeypourFaculty of Chemistry, Bu-Ali Sina University, Hamedan 65174, Iran.
Jamal KouhdarehFaculty of Chemistry, Bu-Ali Sina University, Hamedan 65174, Iran.
Sedigheh AlaviniaDepartment of Organic Chemistry, Faculty of Chemistry, Bu-Ali Sina University, Hamedan 65174, Iran.
Rahman Karimi-NamiDepartment of Chemistry, Faculty of Science, University of Maragheh, Maragheh 55181-83111, Iran.
İdris KarakayaDepartment of Chemistry, College of Basic Sciences, Gebze Technical University, Gebze 41400, Turkey.ORCID https://orcid.org/0000-0002-3590-7206
Bu-Ali Sina University · IRGebze Technical University · TRUniversity of Maragheh · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective oxidation of active and inactive alcohol substrates and reduction of nitroarenes is a highly versatile conversion that remains a challenge in controlling functionality and adjustments in metal-organic frameworks (MOFs). On the other hand, it offers an attractive opportunity to expand their applications in designing the next generation of catalysts with improved performance. Herein, a novel mixed MOF consisting of supported 2-hydroxybenzamide (mixed MOF-salinidol) has been fabricated by post-synthetic modifications of mixed MOF. Subsequently, the prepared nanocomposites were modified to impart catalytic sites using palladium chloride ions mixed with MOF-salinidol/Pd (II). After successfully designing and structurally characterizing nanocomposites, we evaluated their activity in oxidizing primary and secondary alcohols using aerobic conditions with molecular oxygen and an air atmosphere. In addition, the stability of (mixed MOF-salinidol/Pd (II)) catalysts under catalytic conditions was also demonstrated by comparing the Fourier-transform infrared spectrum, scanning electron microscopy image, and ICP-OES method before and after catalysis. Based on the results, the active surface area of the synthesized nanocatalyst is large, which highlights its unique synergistic effect between post-synthetic modified MOF and Pd, and furthermore, the availability of catalytic sites from Pd, as demonstrated by outstanding catalytic activity.

Identifiers

PMID37360424
PMCPMC10285956
OpenAlexW4379618275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.